The choice of antiplatelet and antithrombotic therapy in an elderly patient presenting with STEMI during primary PCI (case report)

DOI: https://doi.org/10.25512/DIR.2015.09.4.13

For quoting:
Teplyakov D. V., Tkhagapsov A. Z., Nazarov E. M., Piltakyan V.K., Volkov A.V. "The choice of antiplatelet and antithrombotic therapy in an elderly patient presenting with STEMI during primary PCI (case report)". Journal Diagnostic & interventional radiology. 2015; 9(4); 87-91.

authors:

Teplyakov D. V.

Tkhagapsov A. Z.

Nazarov E. M.

Piltakyan V.K.

Volkov A.V.

keywords:

acute coronary syndrome

percutaneous coronary intervention

elderly patients

antiplatelet and antithrombotic therapy

Abstract:

Aim: was to review the efficiency of complex methods of bleeding prevention in elderly patients with acute coronary syndrome (ACS) receiving combined anticoagulant and antiplatelet therapy during percutaneous coronary interventions (PCI).

Materials and methods: between January of 2011 to 2015 in «Pokrovskaya City Hospital» of St. Petersburg, 1435 PCI were performed in patients with ACS, the percentage of patients older than 80 years was more than 9%. To reduce bleeding risk we used: transradial access, diminished time of eptifibatide infusion, bivalirudin, intraoperative control of activated clotting time (ACT).

Results: significant decrease of bleeding episodes in patients with high risk of bleeding requiring transfusion at 0, 25% in the early postoperative period was shown.

Conclusions: the reduction of the bleeding risk will increase management efficiency among patients undergoing PCI.

References

1. Biostatistical Fact Sheet: Older Americans and Cardiovascular Diseases. Chicago, AHA, 1998.

2. Rich M.W. et al. PRICE-2 Investigators. Am. J. Geriart. Cardiol. 2003;12(5):307-18, 327.

3. Angeja B., Rundle A., Death or nonfatal stroke in patients with acute myocardial infarction. Am. J. Card. 2001 Mar 1;87(5):627-30.

4. Tiefenbrunn A.J. et al. A report from the NRMI -2. J. Am. Coll. Card. 1998;31: 1240.

5. Thiemann D.R., Coresh J., et al.: Lack of benefit for intravenous thrombolysis in patients with MI who are older than 75 years. Circulation. 2000;101: 2239.

6. Brown D. Deaths associated with platelet glycoprotein 11 b/111 a treatment. Heart. 2003 May;89(5): 535-7.

7. ESPRIT Investigators. Lancet. 2000;356:2037-44

8. Fung et al. The Brief-PCI Trial. JACC 53: 2009: 837-45.

9. Gibson C.M., Morrow D.A., Murphy S.A., et al. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI 30 trial. J. Am. Coll. Cardiol. 2006; 47:2364-73.

10. Bertrand O.F. Meta-Analysis Comparing Bivalirudin Versus Heparin Monotherapy on Ischemic and Bleeding Outcomes After Percutaneous Coronary Intervention. Am. J. Cardiol. 2012; 110:599-606.

11. Marso S.P, Amin A.P Assotiation between of bleeding avoidance strategies and risk of bleeding among patients undergoing PCI. JAMA. 2010 2; 303 (21): 2156-64.

12. Mehran R., Lansky A.J., Witzenbichler B., et al. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomized controlled trial. Lancet. 2009; 374:1149-59.

13. Reduction in Cardiac Mortality With Bivalirudinin Patients With and Without Major Bleeding. Gregg W. Stone et all. J. Am. Coll. Cardiol. 2014;63:15-20.

14. Michael Lincoff A., John A. Bittl. Bivalirudin and Provisional Glycoprotein 11 b/111 a Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockad During Percutaneous Coronary Intervention. REPLACE-2 Randomized Trial. JAMA. 2003 February; 289: 19.

15. Stone G.W., White H.D., Ohman E.M., et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet. 2007; 369:907-19.

16. Lopotovskiy P.Yu., Parkhomenko M.V., Larin A.G., Korobenin A.Yu. Primenenie bivalirudina v klinicheskoi praktike. [The use of bivalirudin in clinical practice.] Diagnosticheskaya i intervencionnaya radiologia. 2012 (6) #4: 79-88 [in Russ].